SCHEMBL3016046

SCHEMBL3016046

O=C(CCc1cccc(Cl)c1)Nc1cc(Cl)ccc1-c1nnn[nH]1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.49
MAPK1 P28482 1/20 0.49
SMN1; SMN2 Q16637 3/20 0.46
CSNK1D P48730 1/20 0.45
HCAR2 Q8TDS4 1/20 0.43
CACNA1G O43497 1/20 0.41
CDK8 P49336 1/20 0.40
KMT2A Q03164 3/20 0.40
TRPV1 Q8NER1 2/20 0.40
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 2/20 0.39
CNR1 P21554 1/20 0.39
LMNA P02545 1/20 0.39
TSHR P16473 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
RAB9A P51151 1/20 0.38
PLAAT3 P53816 1/20 0.38
PLAAT5 Q96KN8 1/20 0.38
PLAAT2 Q9NWW9 1/20 0.38
PLAAT4 Q9UL19 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1309189 0.93 ALOX15 (0.59) ALOX15MAPK1SMN1; SMN2HCAR2KMT2A
SCHEMBL3016713 0.90 ALOX15 (0.49) ALOX15MAPK1SMN1; SMN2HCAR2CACNA1G
SCHEMBL1308602 0.84 L3MBTL1 (0.52) ALOX15MAPK1SMN1; SMN2KMT2AALDH1A1
SCHEMBL1309054 0.83 POLB (0.55) MAPK1SMN1; SMN2KMT2AALDH1A1MEN1
SCHEMBL15752071 0.83 GSK3B (0.48) ALOX15MAPK1SMN1; SMN2KMT2AALDH1A1
SCHEMBL1309175 0.81 ALDH1A1 (0.58) MAPK1SMN1; SMN2KMT2AALDH1A1MEN1
SCHEMBL1308550 0.81 MEN1 (0.54) SMN1; SMN2KMT2AALDH1A1MEN1LMNA
SCHEMBL15751904 0.81 POLB (0.55) ALOX15MAPK1SMN1; SMN2KMT2AALDH1A1
SCHEMBL1308253 0.81 POLB (0.41) ALOX15MAPK1SMN1; SMN2KMT2ATRPV1
SCHEMBL1308217 0.81 MEN1 (0.39) ALOX15MAPK1SMN1; SMN2KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100292283-A1 NOVEL PHENYL-ACETAMIDE AND PHENYL-PROPIONAMIDE DERIVATIVES USEFUL AS POTASSIUM CHANNEL MODULATORS NEUROSEARCH A/S (DK) 2010-11-18 US claimed
EP-2225214-A1 NOVEL PHENYL-ACETAMIDE AND PHENYL-PROPIONAMIDE DERIVATIVES USEFUL AS POTASSIUM CHANNEL MODULATORS NeuroSearch AS (DK) 2010-09-08 EP claimed
WO-2009068557-A1 NOVEL PHENYL-ACETAMIDE AND PHENYL-PROPIONAMIDE DERIVATIVES USEFUL AS POTASSIUM CHANNEL MODULATORS NEUROSEARCH A/S (DK) 2009-06-04 WO claimed
US-20100292283-A1 NOVEL PHENYL-ACETAMIDE AND PHENYL-PROPIONAMIDE DERIVATIVES USEFUL AS POTASSIUM CHANNEL MODULATORS NEUROSEARCH A/S (DK) 2010-11-18 US disclosed
EP-2225214-A1 NOVEL PHENYL-ACETAMIDE AND PHENYL-PROPIONAMIDE DERIVATIVES USEFUL AS POTASSIUM CHANNEL MODULATORS NeuroSearch AS (DK) 2010-09-08 EP disclosed
WO-2009068557-A1 NOVEL PHENYL-ACETAMIDE AND PHENYL-PROPIONAMIDE DERIVATIVES USEFUL AS POTASSIUM CHANNEL MODULATORS NEUROSEARCH A/S (DK) 2009-06-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292283-A1 NOVEL PHENYL-ACETAMIDE AND PHENYL-PROPIONAMIDE DERIVATIVES USEFUL AS POTASSIUM CHANNEL MODULATORS KCNN2, KCNN1, KCNN3 ALOX15 3952/4885MAPK1 1196/4885SMN1; SMN2 2202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.